Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

2024

Efficacy and safety analysis of anlotinib in combination with immune checkpoint inhibitors for second-line and subsequent extensive-stage small-cell lung cancer
Authors: Xixi Ying, Zheng Shi, Rongjun Shao, Guangxian You, Zhengbo Song
Neoplasma Vol.71, No.3, p. 297–305, 2024
doi:10.4149/neo_2024_231104N572
Price: free access
[View Abstract]


Impact of multiple primary cancers on overall survival of patients with hepatocellular carcinoma
Authors: Petr Hříbek, Soňa Fraňková, Johana Klasová, Klára Chmelová, Lucie Miková, Jan Šperl, Petr Urbánek
Neoplasma Vol.71, No.3, p. 289–296, 2024
doi:10.4149/neo_2024_231217N649
Price: free access
[View Abstract]


Circular RNA IARS modulates the progression and ferroptosis of osteosarcoma via sponging miR-188-5p from RAB14
Authors: Yafei Li, Yan Zhang, Xiaohong Lu, Ruie Li, Jiayu Peng, Yangbo Xu
Neoplasma Vol.71, No.3, p. 279–288, 2024
doi:10.4149/neo_2024_240312N111
Price: free access
[View Abstract]


ARTN-GFRA3 axis induces epithelial-mesenchymal transition phenotypes, migration, and invasion of gastric cancer cells via KRAS signaling
Authors: Xiao-Long Wang, Gui-Xiu Jin, Xiao-Qiang Dong
Neoplasma Vol.71, No.3, p. 266–278, 2024
doi:10.4149/neo_2024_231006N524
Price: free access
[View Abstract]


NEK2 promotes TP53 ubiquitination to enhance the proliferation and migration of TP53 wild-type glioblastoma cells
Authors: Yu Zhang, Hao Yu, Mengyao He, Wenchao Liu, Shengyou Xiao, Xiangting Wang, Ping Huang, Qiang Huang
Neoplasma Vol.71, No.3, p. 255–265, 2024
doi:10.4149/neo_2024_240226N80
Price: free access
[View Abstract]


Allicin inhibits the growth of HONE-1 and HNE1 human nasopharyngeal carcinoma cells by inducing ferroptosis
Authors: Xin Li, Jin-Que Luo, Xue-Qi Liao, Shuo Zhang, Li-Fan Yang, Tao Wu, Ling Wang, Qing Xu, Bin-Sheng He, Zhen Guo
Neoplasma Vol.71, No.3, p. 243–254, 2024
doi:10.4149/neo_2024_240108N8
Price: free access
[View Abstract]


Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway
Authors: Guang Yang, Yun Wang, Kairui Wang, Xinjia Liu, Jing Yang
Neoplasma Vol.71, No.3, p. 231–242, 2024
doi:10.4149/neo_2024_230904N469
Price: free access
[View Abstract]


Silencing of lncRNA LOC105376794 promotes migration, invasion, and gefitinib resistance of lung adenocarcinoma cells with EGFR 19del mutation by ATF4/CHOP axis and ERK phosphorylation
Authors: Wenjing Liu, Zhipeng Duan, Yefeng Wu, Rui Ma
Neoplasma Vol.71, No.3, p. 219–230, 2024
doi:10.4149/neo_2024_230616N316
Price: free access
[View Abstract]


Downregulation of WNK4 expression facilitates the proliferation of gastric cancer cells via activation of the STAT3 signaling pathway
Authors: Miao Li, Xiaoyan Shao, Qiqi Ning, Rongrong Sun, Rantian Li, Yanhua Liu, Yuan Yuan, Youwei Zhang
Neoplasma Vol.71, No.3, p. 209–218, 2024
doi:10.4149/neo_2024_240220N67
Price: free access
[View Abstract]


Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia
Authors: Vesna Bišof, Andrija Katić, Majana Soče, Marina Vidović, Jelena Viculin, Stjepko Pleština, Eduard Vrdoljak
Neoplasma Vol.71, No.2, p. 201–208, 2024
doi:10.4149/neo_2024_231209N633
Price: free access
[View Abstract]


Characterization of the effects of thymol derivatives on colorectal cancer spheroids
Authors: Michaela Blažíčková, Mária Bučková, Katarína Kozics
Neoplasma Vol.71, No.2, p. 193–200, 2024
doi:10.4149/neo_2024_231222N658
Price: free access
[View Abstract]


Calreticulin regulates the expression of MMP14 and ADAR1 through EIF2AK2 signaling to promote the proliferation and progression of malignant melanoma cells
Authors: Li Liang, Jin Wang, Tao Guo, Lijun Huang, Yanping Wu, Rui Xu, Tong Huang, Binghua Ma
Neoplasma Vol.71, No.2, p. 180–192, 2024
doi:10.4149/neo_2024_240116N24
Price: free access
[View Abstract]


Unlocking the paracrine crosstalk: adipocyte-derived factors affect carbonic anhydrase IX expression in colon and breast cancer cells
Authors: Jana Lapinova, Miroslav Balaz, Lucia Balazova, Lucia Csaderova, Tereza Golias, Miriam Zatovicova, Joerg Heeren, Silvia Pastorekova, Martina Takacova
Neoplasma Vol.71, No.2, p. 164–179, 2024
doi:10.4149/neo_2024_240321N127
Price: free access
[View Abstract]


Nanocomposite hydrogels in skin cancer medicine
Authors: Lucia Balintova, Michaela Blazickova, Monika Sramkova
Neoplasma Vol.71, No.2, p. 153–163, 2024
doi:10.4149/neo_2024_240315N118
Price: free access
[View Abstract]


Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targets
Authors: Eva Lukáčová, Ondrej Pös, Eva Túryová, Tatiana Hurtová, Zuzana Hanzlíková, Tomas Szemes, Tatiana Burjanivová
Neoplasma Vol.71, No.2, p. 143–152, 2024
doi:10.4149/neo_2024_240207N58
Price: free access
[View Abstract]


Can hypoxia marker carbonic anhydrase IX serve as a potential new diagnostic marker and therapeutic target of non-small cell lung cancer?
Authors: Silvia Fecikova, Lucia Csaderova, Petra Belvoncikova, Barbora Puzderova, Kamila BernatovA, Tomas Talac, Jaromir Pastorek, Monika Barathova
Neoplasma Vol.71, No.2, p. 123–142, 2024
doi:10.4149/neo_2024_231219N652
Price: free access
[View Abstract]


Participation of suicide gene extracellular vesicles in metastasis prevention
Authors: Dajana Vanova, Michal Andrezal, Jana Jakubechova, Ursula Altanerova, Cestmir Altaner
Neoplasma Vol.71, No.2, p. 117–122, 2024
doi:10.4149/neo_2024_240208N59
Price: free access
[View Abstract]


Mouse models for cancer research – current state and the perspective
Authors: Katarina Gercakova, Martina Poturnajova, Silvia Tyciakova, Ingeborg Rezuchova, Miroslava Matuskova
Neoplasma Vol.71, No.2, p. 99–116, 2024
doi:10.4149/neo_2024_240328N140
Price: free access
[View Abstract]


Three years follow-up of neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
Authors: Wenhao Ji, Youhua Jiang, Yuetong Li, Weimin Mao, Lisong Teng
Neoplasma Vol.71, No.1, p. 88–97, 2024
doi:10.4149/neo_2024_230517N262
Price: free access
[View Abstract]


Albumin-to-D-dimer ratios: A novel prognostic factor for evaluating first-line chemotherapy efficacy in advanced lung adenocarcinoma patients
Authors: Liqun Zhang, Xing Li, Zhuo Wang, Zhiyan Zhang, Lei Zhang, Zhaoyang Liu, Lisha Zhang, Shuowen Wang, Tatiana Vitalevna Khorobrykh, Mingze He, Jiawen Xiao
Neoplasma Vol.71, No.1, p. 77–87, 2024
doi:10.4149/neo_2024_230413N205
Price: free access
[View Abstract]





Display #  
Results 1 - 20 of 27

© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.